WallStreetZenWallStreetZen

NASDAQ: ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ARCT

Based on 7 analysts offering 12 month price targets for ARCTURUS THERAPEUTICS HOLDINGS INC.
Min Forecast
$17.00+2.22%
Avg Forecast
$51.29+208.39%
Max Forecast
$105.00+531.39%

Should I buy or sell ARCT stock?

Based on 8 analysts offering ratings for ARCTURUS THERAPEUTICS HOLDINGS INC.
Hold
Strong Buy
3 analysts 37.5%
Buy
0 analysts 0%
Hold
3 analysts 37.5%
Sell
0 analysts 0%
Strong Sell
2 analysts 25%

ARCT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Anonymous
Goldman Sachs
Strong SellMaintains$8.00-51.89%2022-05-24
Baird
Top 19%
82
HoldUpgrades$18.00+8.24%2022-05-11
Barclays
Top 20%
81
Strong SellMaintains$17.00+2.22%2022-05-10
HC Wainwright & Co.
Bottom 3%
3
HoldMaintains$19.00+14.25%2022-05-10
Wells Fargo
Bottom 23%
23
Strong BuyMaintains$105.00+531.39%2022-03-25
Citigroup
Bottom 4%
4
Strong BuyMaintains$86.00+417.14%2022-03-15
Raymond James
Bottom 2%
2
HoldUpgradesN/AN/A2022-01-31
Goldman Sachs
Top 2%
99
Strong SellDowngrades$29.00+74.38%2021-08-11
Cantor Fitzgerald
Bottom 15%
15
Strong BuyMaintains$85.00+411.12%2021-08-10

1 of 1

Forecast return on equity

Is ARCT forecast to generate an efficient return?
Company
198.2%
Industry
78.55%
Market
30.86%
ARCT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ARCT forecast to generate an efficient return on assets?
Company
107.07%
Industry
21.31%
ARCT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ARCT earnings per share forecast

What is ARCT's earnings per share in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
-$6.66
Avg 2 year Forecast
$1.79
Avg 3 year Forecast
$7.67

ARCT revenue forecast

What is ARCT's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$38.2M+147.1%
Avg 2 year Forecast
$326.9M+2,012.4%
Avg 3 year Forecast
$542.6M+3,406.33%
ARCT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ARCT revenue growth forecast

How is ARCT forecast to perform vs Biotechnology companies and vs the US market?
Company
227.3%
Industry
17.95%
Market
8.91%
ARCT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ARCT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ARCT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ARCT$16.63$51.29+208.39%Hold
KPTI$5.52$13.50+144.57%Buy
ATRA$4.69$19.67+319.34%Buy
IMTX$6.95$25.00+259.71%Buy
VERA$16.14$30.33+87.94%Buy
View Top Biotech Stocks

ARCTURUS THERAPEUTICS HOLDINGS Stock Forecast FAQ

Is ARCTURUS THERAPEUTICS HOLDINGS Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: ARCT) stock is to Hold ARCT stock.

Out of 8 analysts, 3 (37.5%) are recommending ARCT as a Strong Buy, 0 (0%) are recommending ARCT as a Buy, 3 (37.5%) are recommending ARCT as a Hold, 0 (0%) are recommending ARCT as a Sell, and 2 (25%) are recommending ARCT as a Strong Sell.

What is ARCT's earnings growth forecast for 2022-2024?

(NASDAQ: ARCT) ARCTURUS THERAPEUTICS HOLDINGS's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 7.24%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.71%.

ARCTURUS THERAPEUTICS HOLDINGS's earnings in 2022 is -$198,497,000.On average, 5 Wall Street analysts forecast ARCT's earnings for 2022 to be -$175,950,307, with the lowest ARCT earnings forecast at -$204,218,599, and the highest ARCT earnings forecast at -$160,891,497. On average, 4 Wall Street analysts forecast ARCT's earnings for 2023 to be $47,289,947, with the lowest ARCT earnings forecast at -$135,793,480, and the highest ARCT earnings forecast at $181,234,100.

In 2024, ARCT is forecast to generate $202,633,462 in earnings, with the lowest earnings forecast at -$55,744,016 and the highest earnings forecast at $709,085,021.

What is ARCT's revenue growth forecast for 2022-2024?

(NASDAQ: ARCT) ARCTURUS THERAPEUTICS HOLDINGS's forecast annual revenue growth rate of 227.3% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 17.95%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 8.91%.

ARCTURUS THERAPEUTICS HOLDINGS's revenue in 2022 is $15,476,000.On average, 4 Wall Street analysts forecast ARCT's revenue for 2022 to be $1,010,287,641, with the lowest ARCT revenue forecast at $679,680,713, and the highest ARCT revenue forecast at $1,441,418,730. On average, 4 Wall Street analysts forecast ARCT's revenue for 2023 to be $8,636,755,943, with the lowest ARCT revenue forecast at $1,269,853,972, and the highest ARCT revenue forecast at $14,764,766,970.

In 2024, ARCT is forecast to generate $14,335,960,749 in revenue, with the lowest revenue forecast at $3,885,780,629 and the highest revenue forecast at $35,669,037,215.

What is ARCT's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: ARCT) forecast ROA is 107.07%, which is higher than the forecast US Biotechnology industry average of 21.31%.

What is ARCT's Price Target?

According to 7 Wall Street analysts that have issued a 1 year ARCT price target, the average ARCT price target is $51.29, with the highest ARCT stock price forecast at $105.00 and the lowest ARCT stock price forecast at $17.00.

On average, Wall Street analysts predict that ARCTURUS THERAPEUTICS HOLDINGS's share price could reach $51.29 by May 11, 2023. The average ARCTURUS THERAPEUTICS HOLDINGS stock price prediction forecasts a potential upside of 208.39% from the current ARCT share price of $16.63.

What is ARCT's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: ARCT) ARCTURUS THERAPEUTICS HOLDINGS's current Earnings Per Share (EPS) is -$7.53. On average, analysts forecast that ARCT's EPS will be -$6.66 for 2022, with the lowest EPS forecast at -$7.73, and the highest EPS forecast at -$6.09. On average, analysts forecast that ARCT's EPS will be $1.79 for 2023, with the lowest EPS forecast at -$5.14, and the highest EPS forecast at $6.86. In 2024, ARCT's EPS is forecast to hit $7.67 (min: -$2.11, max: $26.84).

What is ARCT's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: ARCT) forecast ROE is 198.2%, which is considered strong.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending StocksStock Market SectorsStock Market Industries
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.